Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,000 shares at $37.96 ($228K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
Open-market sale of $228k RARE by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |
| RARE | SELL | 2023-03-03 | $166K | — | Filing → |